# The Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations

> **NCT00286897** · PHASE3 · COMPLETED · sponsor: **Eisai Limited** · enrollment: 702 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** E2007

## Key facts

- **NCT ID:** NCT00286897
- **Lead sponsor:** Eisai Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** 2007-06
- **Final completion:** 2007-08
- **Target enrollment:** 702 (ACTUAL)
- **Last updated:** 2015-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00286897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00286897, "The Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00286897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*